Cytokinetics, Incorporated (CYTK) has a market capitalization of $8.17B and trades at $66.35. The 52-week range is 29.31-70.98.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -10.1, Earnings Per Share (EPS) of $-6.54, annual revenue of $88.04M.
The stock has a beta of 0.48, operates in the Healthcare sector.
